NervMyo Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
NervMyo Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at NervMyo Therapeutics
Erica Lee
Co-Founder And Ceo
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About NervMyo Therapeutics
NervMyo Therapeutics is developing long-acting, injectable therapy treatments to improve nerve regrowth and prevent muscle wasting after nerve injury.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
NervMyo Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
NervMyo Therapeutics has never raised funding before.
Singapore
United Kingdom
FranceFrequently asked questions
NervMyo Therapeutics is located in XX.
NervMyo Therapeutics generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
NervMyo Therapeutics has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
NervMyo Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
NervMyo Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
